 |
June 2008 Archives
The late Congressman Tom
Lantos in November 2007 lambasted Yahoo CEO Jerry Yang for outing a Chinese
journalist who was arrested as a result of information provided to the
communist government by Yahoo.
Lantos called Yang a "moral pigmy" for caving in to a request of the
Chinese government for disclosure of evidence used to prosecute a journalist
and send him to prison.
Now, the House of
Representatives by a vote of 293-129 has capitulated on a major civil liberty
by indemnifying telecommunications companies for committing the same act in
this country. If these changes to the Foreign
Intelligence Surveillance Act pass the Senate
it will insulate telecommunications companies from lawsuits for the Bush
Administration's warrantless eavesdropping on phone and computer lines.
Some will argue there is a
big difference between the totalitarian government of the Chinese and the
current Bush Administration.
The current Bush administration is decidedly authoritarian and acts very much like the Chinese government in many ways.
The Chinese torture
political prisoners; the Bush Administration tortures political prisoners. The Chinese are not bound by
Constitutional principles; the Bush Administration does not see itself bound by
Constitutional principles. The
Chinese run an oppressive political machine that squelches free speech; the
Bush-Rove operation has attempted to do likewise. The Chinese spy on their citizens; the Bush Administration
spies on its citizens and supports the wholesale investigation of telephone
records, without a warrant or respecting existing statutory safeguards.
Both governments use the
ruse of national security to justify their actions. If you have been thinking about boycotting the Chinese Olympics advertisers, which is a very good idea, we need equivalent action in the U.S. against the U.S. government.
To allow communications
companies to give up confidential telephone records to the government on
request is an outrageous erosion of civil liberties. It is the same as Yahoo executives declaring they must
follow the law in China. The
despicable acts our government have asked of the telecom companies are headed towards
becoming sanctified by law.
Benjamin Franklin said,
"Those who give up essential liberty to obtain a little temporary safety
deserve neither liberty nor safety."
This administration, using
9/11 as a bloody shirt, have continually worked to erode the Constitution and
basic liberties. What Bush and a
previous Republican majority in Congress have done is so outrageous that even a
fundamentally conservative court struck down the statute they enacted to
suspend the constitutional right of habeas corpus.
In Boumediene v. Bush,
decided June 2008 the Supreme Court held that individuals on American soil at
Guantanamo Bay could not be denied access to the courts protected by via a writ
of habeas corpus. The 5-4 decision has been
heavily criticized by John McCain.
Mr. McCain believes that people held in American prisons at Guantanamo
should not have the right to have our courts decide if their imprisonment for
years is legal.
Since when is it OK for a
free nation to arrest any person, for any conduct, and then pass a law to
prohibit them from asking a court to decide if their imprisonment is
legal? This is the United States
of America, not the 20th century Soviet Union.
Professor Richard Epstein,
University of Chicago Law School, wrote an amicus brief for the prisoners. He got it right in an op-ed to the New
York Times: "Boumediene v. Bush is not a license to allow hardened terrorists
to go free. It is a rejection of the alarmist view that our fragile
geopolitical position requires abandoning our commitment to preventing Star
Chamber proceedings that result in arbitrary incarceration."
Our four arch-conserative
justices were just one vote away from holding that allowing the writ of habeas
corpus would constitute reckless judicial intervention in military matters. I call them the TSARs [Thomas, Scalia, Alito and Roberts] because thats what we would have for a Supreme Court if McCain gets elected and gives them one more vote.
But for the intercession of a Democratic Congress in 2006, the foundations of a totalitarian state were underway, which is why this most recent vote to endorse surveillance of the telecoms is a total outrage. Spying on citizens, locking up people
and denying them the writ of habeas corpus and condoning torture are not the
hallmarks of a free society or a public morality worth emulating. I have written about the Bush
Administrations wholesale abuse of the Constitution before. The bill approved on June 20, 2008 allows for mass, untargeted and unwarranted surveillance of all communications coming in to and out of the United States. The courts' role is that of a rubber stamp and it is useless; the government can continue spying on our communications even after the FISA court has objected. 293 "representatives" [a classic oxymoron] approved a wholesale giveaway of our Fourth Amendment rights.
Tom Lantos must be rolling
over in his grave. His own beloved
country is advocating a national policy to legalize the very immoral acts that
he condemned Yahoo for committing in communist China.
Those who forget history are
condemned to relive it.
Tom Lantos was all too aware
of the slippery slope that leads to totalitarianism, having survived the Nazi
regime. To say that it cannot
happen in this country is to ignore history. It can happen anywhere. To say
that it is not happening in this country is to ignore reality.
If we are to preserve "liberty and justice for all" we must be resoundingly say "no" to
giving up rights here, and then there, and then everywhere. Freedom is nonnegotiable. That
must apply to the Bush administration, to telecom companies, and to corporate
executives. If freedom is to
flourish good men and women cannot be idle. This 293-129 vote is a bad idea.
As Dante said, "the hottest
places in hell are reserved for those who in times of moral crisis preserve
their neutrality."
My views of the
Surveillance Bill were best expressed by Rep. Zoe Lofgren, a leading voice of
reason on the House Judiciary Committee.
On the floor of the House she said: " Mr. Speaker, this bill
goes far beyond what is necessary
and what was agreed to by the Director of National Intelligence. All of us
agree that foreign-to-foreign communications need to be available for
surveillance. However, this bill would grant the Attorney General the ability
to wiretap anybody, anyplace, anytime, without court review,
without any checks and balances. This unwarranted, unprecedented measure would
simply eviscerate the fourth amendment that protects the privacy not of
terrorists, but of Americans. I strongly oppose this warrantless surveillance
measure." Well said Representative Lofgren. Thank you.
The Senate must kill this bill. Filibuster if they must, but they must
kill it for the sake of "liberty and justice for all."
It is a lesson Congressman
Tom Lantos knew well. Onward,
Richard Alexander
For those of us who cherish
civil liberties, the last thing we need is Sen. John McCain in the Oval
Office. What many people
don't think about when pulling the lever in the voting booth is that the president
appoints judges that control their lives - not only appointments to the U.S.
Supreme Court, but up and down the federal judiciary.
Senator McCain's "positions are
nearly identical to the president's on abortion and the types of judges he says
he would appoint to the courts," "How
Close McCain Is to Bush Depends on the Issue," New York Times, June 17, 2008. President Bush's arch-conservative choices for the Supreme Court are one vote away from a majority. One more appointment by either President Bush or Mr. McCain, if elected president, would mean a stunning reversal for human rights.
On June 12, 2008 the
Supreme Court by just a 5-4 vote held that terror suspects held at the U.S.
Naval Base at Guantanamo Bay could not be denied the right to file a habeas
corpus petition to challenge why they were being held.
The news stories of
the day claimed a great triumph for democracy. The linked piece is just one
example of many television, radio and press stories that totally missed the
point.
To anyone who claimed
this was a "great triumph" or the like, that's a frightening conclusion.
This decision was a near disaster. Habeas corpus should be protected by a 9-0 vote. This 5-4 decision mirrors the U.S. criminal justice system, which has the highest number of people behind bars in the world. Even more than in China. That is a stunning indictment of a "sink or swim" society and raises serious questions about the law that your courts are enforcing and just how uncivilized a society we have allowed the United States to have become. Law and order is fine, but for all the law, we don't have much order. The statute denying the historic protection of habeas corpus with the purpose of taking away the supervisory function of the courts was drafted and supported by John McCain. And his favorite judges
- the kind he would appoint - voted against this necessary constitutional restraint on illegal
government actions. Chief Justice John Roberts,
and associate justices Samuel Alito, Antonin Scalia and Clarence Thomas - whom
Bush senior lied about when he said Thomas was the most qualified person he could appoint - all were the dissenters.
Thomas, Scalia, Alito and Roberts, our TSARs in waiting, would love to have just one more reactionary vote to chisel away more of the
underpinnings of our Constitution and put an end to individual rights.
Here's how it works for the TSARs: Business and government uber
alles. Personal rights last.
In March a 4-4 split court in Warner-Lambert v. Kent didn't have the five votes
needed to take on the question whether a product liability claim could be
brought be against a manufacturer of an FDA approved drug.
You were one vote away from losing your personal right to sue for personal
injuries caused by dangerous drugs: Trasylol which causes kidney failure, Ortho
Evra that causes stroke and heart attacks, MRI contrast solutions with
gadolinium that are lethal for kidney patients, Zyprexa that causes diabetes
and Vioxx the pain killer that kills. And those are just a few of the currently dangerous drugs without opening the archives.
With one more vote the United States Supreme Court could have granted legal
immunity to pharmaceutical manufacturers on the legal theory that once a defective drugs had been
approval by the FDA, even though proven to be unsafe and dangerous, no further questions can be asked in a court of law. The TSARs wants to turn over total control of regulating drugs to the FDA, a proven administrative disaster, and allow drug companies to profit by selling highly questionable, and sometimes known dangerous drugs, without allowing victims a chance to hold them responsible in front of a judge and jury.
Don't doubt for a minute
that isn't likely to happen.
That's why we need a
Democratic president. Voters should stand proud of the voice they gave to Obama and Clinton. It was an historic race. Sen. Clinton made a spectacular run against a culture of misogyny and Sen. Obama proved it was the person, and not the color, that counted.
But it can be even more. An Obama-Clinton ticket means more than the vote's of18 million Clinton
supporters and it's more than merely seeking women to support the Democratic
ticket. It would show Obama's
commitment to real change at two levels. First, at a very personal level, Obama could show that to change the
country he is willing to change himself. Secondly, that leadership action would cement his position as the most
committed Democratic leader since Franklin Roosevelt.
USA Today on June 10 2008
described on page one the changes on abortion, job bias, and campaign finance
and racial polices that have occurred since the retirement of Sandra Day
O'Connor from the Supreme Court in January 2006. In short, Justice O'Connor's legacy has faded.
Imagine how bad it would be
with the next Supreme Court justice appointed by McCain, giving the TSARs a
solid Supreme Court majority.
We are on the cusp. A Democrat in the White House is a
must. An Obama-Clinton ticket
guarantees a Democratic win - a win that we must have to protect ourselves against right-wing abuse on the Supreme Court and to preserve human rights. This is not the time for risk. There is way too much to lose. There is so much to protect. Onward.
Richard Alexander
Two
members of the Tongan Royal Family, visiting the San Francisco area to discuss
political reforms in their tiny South Pacific nation, stepped into a Ford
Explorer for a short ride to a meeting with the Tongan community. Instead, because of decisions made by Ford
executives, the Explorer gave the royals a ride to their deaths.
A teenage driver in a 1998 Ford Mustang on U.S. 101 in Menlo Park, California
cut off the 1998 Explorer in which Prince Uluvala Tu'ipelehake and Princess
Kaimana Tu'ipelehake were passengers.
The Mustang was going no more than 10 miles hour faster than the Explorer when it moved left into the Explorer's lane and struck the bumper. The Explorer swerved to the right, and the driver over-corrected, causing the Explorer to trip and roll, killing both passengers and their driver.
The
teen driver, Edith Delgado, was found guilty of misdemeanor vehicular
manslaughter, and was sentenced to two years in county jail, but the Explorer was the real
culprit.
Ford
executives deserve jail time for the deaths of the Tongan visitors and the deaths of hundreds of others whose fates were sealed in Explorers.
Delgado
cut off the Explorer and caused it to make a swerve to the right. Then, as expected, the driver lost control of the Explorer when she jerked the wheel back to the left and the Explorer did what it was
designed to do. It rolled on a flat level road.
The
real proof of the Explorer's instability is Delgado's Mustang. The Mustang suffered minor
damage. I bought it and had it
driven to my warehouse for storage as evidence in the lawsuit I filed against
Ford on behalf of the Prince's two sons.
Ford's
management knew that the Explorer would roll and kill people when they first
marketed it in 1990. The Explorer was a replacement for the equally dangerous
Bronco II, and Ford's decision to sell a new model that was certain to cause
deaths and horrific injuries continued a pattern of behavior that went back at
least 20 years to the Pinto and its exploding gas tank.
Ford
engineers told management the Explorer was unstable and had major handling
flaws long before the first Explorer came off the assembly line,
but Ford's decision makers smelled big profits from the "First Mover"
market position that the Explorer would give them.
As
the executives hoped, they made their huge profits. As expected, Explorers
rolled, people died, and continue to die. In
California alone, from 1990 to 2000, the Explorer earned Ford more than $2
billion in profits, and Dr. Alan Goedde, an expert witness, calculated the
First Mover portion of the profits at between $383 million and $442 million. Rollover
problems began with the Explorer as soon as it hit the streets. Its center of
gravity was too high and its wheelbase was too narrow. Every extra passenger
raised the center of gravity even higher, making the vehicle even more unstable and the roof was not nearly strong enough to protect passengers when
rollovers did occur.
Defective
Firestone tires were a major contributing factor in many Explorer rollovers. Those
tires frequently separated and caused Explorers to spin wildly out of control. Disintegrating tires caused severe personal injuries and deaths, but when Ford
became aware of problems with tires, it approved replacement tires from other
manufacturers that made the Explorer even more dangerous.
Knowing the risks that the Explorer presented, Ford never slowed its
marketing efforts. Suburban housewives and city residents who thought they were
driving the equivalent of a station wagon were placing their families in trucks
that didn't meet federal automobile safety standards. And when evidence showed that Explorers were killing and
maiming people, Ford sent out its lawyers and PR people to attempt to cover up its
misdeeds.
Despite
all the deaths, injuries, and lawsuits, the Explorer is still on on a roll - literally. In
government tests on the 2008 Explorer, it received only a 3 (of a possible 5)
in rollover safety.
Henry
Ford wouldn't be happy with the profits-before-lives approach that his
company has taken. Mr. Ford was a pacifist who once faced a lawsuit from his
own shareholders because he was more interested in the welfare of his workers
than in maximizing his profits.
Henry Ford was a socially responsible manager with a conscience. We know what Henry would say about the Explorer if he were alive today. Too bad his conscience is no longer at the helm.
Onward.
Richard
Alexander
Kudos to Evelyn Pringle of
the Media Monitors Network for an excellent case study of how drug companies
promote profits by paying for research supporting off-label uses for their products. "Just What Kids Need - Sparlon - Another ADHD Drug" (March
2006).
The report features DuBose
Ravenel, MD, a pediatrician with 25 years experience with ADHD children, who
testified for the International Center for the Study of Psychiatry and
Psychology at the FDA's March 23, 2006 meeting of the Psychopharmacologic Drugs
Advisory Committee and blew the whistle on Joseph Biederman's conflict of
interest in his research supporting an off-label use for an ADHD drug.
Together Evelyn Pringle and
Dr. Ravenel raised ethical
questions of Dr. Biederman relationships to a drug companies. Add that to the recent revelations by the New York Times' "Researchers Fail to Reveal Drug Pay"
June 8, 2008 and you will see why I recommended in my previous article on this topic that Harvard make a public example of their "payola" faculty by firing them. Here is what Ms. Pringle wrote in March 2006.
"The pharmaceutical
company, Cephalon Inc, is going through the motions of legitimizing the sale of
Sparlon for the treatment of ADHD even though its active ingredient, modafinil,
has been heavily promoted and sold under the name Provigil, for off-label
treatment of ADHD by Cephalon for years.
"Last October, the FDA
sent an "approvable" letter to Cephalon for the pediatric use of
Sparlon pending a March 23, 2006, meeting of the Psychopharmacologic Drugs
Advisory Committee to review the drug's approval.
"Modafinil-based Provigil
is currently only approved for narcolepsy, sleep apnea and shift work sleep
disorder, according to the FDA. However, it is estimated that half of all
Provigil prescriptions are written for off-label use.
"Doctors now
prescribe it to treat everything from attention deficit hyperactivity disorder
(ADHD) to fatigue associated with multiple sclerosis and depression,"
according to the November 1, 2004 Business Week Online.
"Cephalon gets nearly half
of its $1.2 billion in annual sales from modafinil.
* * *
"With Sparlon's
application to FDA approval, Cephalon claimed 3 studies involving more than 600
children aged 6 to 17, found the drug to be more effective than a placebo.
* * *
"Dr DuBose Ravenel, MD,
who will testify on behalf of the International Center for the Study of
Psychiatry and Psychology at the advisory committee hearing on March 23, makes
the point that although "48% of drug treated subjects at final follow-up were
"much" or "very much" improved clinically, 52% were not."
"This is a substantially
lower response rate than has been reported for traditional stimulants," the
doctor notes.
Dr Dubose Ravenel is a
pediatrician with 25 years experience in private practice with a heavy emphasis
upon behavioral issues, including diagnosing and managing ADHD.
"In addition, she notes,
with regard to potential conflicts of interest, itemized conflicts for each of
the Pediatric study's authors are numerous.
"For instance, "Dr.
Biederman received research support from 10 companies, serves on speakers'
bureaus for 4 companies, and is on advisory boards of 6 companies,"" Dr Dubose
Ravenel reveals.
"Other authors have
numerous listed conflicts as well she notes.
"In light of recent widely
publicized articles showing widespread deceptive practices engaged in by
pharmaceutical companies in designing, selective reporting, and interpreting
studies," she says, "the large number of pharmaceutical company ties with the
authors of the study do not lend confidence to the reader even beyond the
aforementioned concerns." And "thank you" to Dr. Ravenel for reporting on conflicts of interest in drug research investigations. Good job. Onward. Richard Alexander
Drug company
money influences and corrupts research. That is a given. What is less understood is why drug manufacturers spend billions for research on off-label uses for their products - uses that were never cleared with the FDA when the drug was submitted for approval. Off-label use allows drug companies to get "through the back door" what they could never, and I mean never, get away with by going directly to the FDA for approval for a new use of a product - what is known today as an off-label use.
You would hope
that researchers wouldn't corrupt the commercial experimentation of a new, or off-label, use of a drug to
treat children by covering up their consulting fees from Big Pharma. But that's what happened. More important than what happened is why it happened and at the bottom of all this is a terrible mistake the U.S. has made in allowing the exploitation of off-label use. The devil is in the details, so here is the story as it has unfolded.
Leading
Harvard professors studying off-label uses, the gold mine of the drug industry,
have violated National Institute of Health reporting requirements when more
than $10,000 has been received from a subject company, according to the New
York Times, "Researchers Fail to Reveal Drug Pay" June 8, 2008.
Johnson &
Johnson, Eli Lilly, Merck and the other big time operators, the leading
exploiters of junk science, thrive on talking the FDA into approving a drug for
one use and then encouraging research so doctors will use it for other
purposes. Everybody knows the FDA can't stop toxic food from being unloaded on
Americans. Yet few realize that the drug companies have hired off the FDA's most seasoned
researchers, leaving juniors guarding our public health.
So it is easy to
wing a drug application past the FDA's lap dogs and once that occurs, off-label
use can exploited by the manufacturers.
Off-label use is
allowed under our law on the theory that the doctor knows best, and once a drug
is approved by FDA for one purpose, a physician can prescribe the medication for
other uses. That's where the big
money is in pharmaceuticals.
Off-label drug use accounted for more than 20 percent of drug sales in
2006, according to the Annals of Internal Medicine, which provides an excellent overview of who's in charge of safeguarding patient welfare and FDA off-label
policies.
Drug companies
cannot directly market off-label use.
That's against the law and major companies such as Eli Lilly, Pfizer and
Astrazenica have been prosecuted for doing so and causing serious personal
injuries and deaths. In many cases
the harm caused by off-label continues for years.
That's the case with Wyeth's Pondimin®
and Redux®, better known as Fen-Phen, an off-label use for weight loss that is
responsible for primary pulmonary hypertension. Fen-Phen continues to devastate
lives with tragic and deadly personal injuries a decade after its marketing demise. I know. These innocent victims are my clients.
But what the FDA takes away from drug manufacturers on one hand it gives back on the
other. Today there is a loophole
in prohibitions against marketing off-label use big enough to drive a train
through. Our FDA watch-kittens
have eased the rules which allow drug companies to republish and distribute
scientific articles on the topic.
It's a bad
policy that has been blasted by a leading Stanford researcher, Dr. Randall
Stafford who said so in an editorial in the New England Journal of Medicine in
April 2008.
The drug
companies know the trick is to get someone else to talk about new ways to use
their drugs and then pass on copies of the research articles they cannot
publish themselves to every doctor in the western world under the companies'
First Amendment right to free speech. That's why Merck wrote drug studies for doctors. Drug companies need to have researchers finding new off-label uses. Since pushing research for off-label
use is a key to profitability, that is what drug companies do and to the extent
that it promotes scientific discovery that's good, but it has to be above
board.
Turns out that
Dr. Joseph Biederman, a world-renowned Harvard child psychiatrist and his
Harvard sidekick Dr. Timothy Wilens have been operating below the board. They either cannot count over $10,000, or they have willfully violated NIH mandates and federal reporting requirements.
The duo
collected $1.6 million in unreported consulting fees from drug makers since
2000 to experiment with antipsychotic medicines in children, but nary a
disclosure.
They are not the
only ones.
Dr. Thomas
Spencer, another Harvard professor, pulled down at least $1 million in
unreported drug money and reporting also slipped his mind.
So there must be
more.
Thank you
Senator Charles Grassley for forcing them to disclose. Good work.
Harvard needs to
end this skullduggery by requiring their big league faculty to annually turn in
their tax returns with the W-2s and 1099s attached to guarantee full disclosure
and compliance with ethical research requirements. Then post it on a website. Let them complain.
If they want the Harvard imprimatur, that's the price.
Other major
research institutions also need to make sure that disclosure requirements are
mandatory, not merely "ethical" expectations. If the public and regulators are to have any confidence in
research, the source of funds and the amounts must be publicly disclosed.
Harvard needs to make a strong public statement by making a public example of these outlaws. Saying "sorry" isn't enough.
If Harvard
doesn't fire them, it will be complicit in the cover-up. Throw them off campus. Ring the bell loud and clear that no
matter how renown or stellar, if you don't play by the rules, you can't play at
all. And the NIH should forever
ban them from receiving grants.
Don't throw out
the baby with the bath water. Once
appropriate punishment has been served, give these researchers a chance to
polish their tarnished reputations. Allow them to conduct research under the
supervision of a responsible administrator who knows that "veritas,"
means truth, accuracy, honesty, and uprightness and that it's more than just a
motto.
Onward.
Richard Alexander
Would
you like to turn over control of your health and viability - possibly your very
longevity - to an understaffed, underfunded government bureaucracy? Doesn't appeal to you, does it? The FDA (U.S. Food & Drug
Administration), which if you think about it for a little while, has
extraordinary power over your personal well-being - may gain even more
dominance over your destiny. The
battle for world domination of your body will occur this fall in the august
chambers of the U.S. Supreme Court.
The
foundation of the legal fight is the Vermont Supreme Court decision in Levine
v. Wyeth.
Diana
Levine, a professional musician, was treated, in April 2000, for a severe
migraine headache and nausea.
Staff at the Vermont Health Center injected her with Phenergan, a nausea
medication. They used her arm to administer the injection and the outcome was
very disastrous: she lost her right arm below the elbow, and left the hospital
an amputee.
Levine
sued Wyeth, which sells Phenergan, on the basis that the warning label on
Phenergan - although it complied with FDA requirements - was inadequate. Levine won a jury trial and was awarded
about $6.8 million.
Wyeth
appealed the decision because it wants to hide behind the FDA. The case went to
the Vermont Supreme Court which ruled against Wyeth, saying, in essence, the
drug manufacturer had a duty under state law to strengthen the warning label on
the drug, regardless of the FDA's confusing, and sometime conflicting,
regulations on when, or if, warning labels should be revised.
The
Politics of Pre-Emption At
the heart of the upcoming U.S. Supreme Court battle is the concept of
pre-emption: that federal law pre-empts the right of victims such as Diana
Levine to sue for the damages inflicted upon them in state courts.
The
[supposed] logic is this: if the FDA has approved the drug, or medical device,
and the label, then drug manufacturers need only to comply with the FDA's
requirements to be granted sweeping immunity against personal injury law suits
filed in state court for damages based for failure to warn. Or as the New York Times stated the
drug companies are looking for "a
legal shield" against being held accountable.
Why
is it that major corporations, and many of their Republican supporters, are
always talking about accountability and responsibility, until it comes to them?
The
whole thing is scary.
Here
is an agency - the FDA - which is understaffed and not keeping up with
technology - faced with the possibility of assuming even more control over our
very being. USA Today
published a story - citing an independent panel review of the FDA - which
revealed that the agency has about the same size staff as 15 years ago. According to the article, Instead of being proactive, the agency (FDA) is often
in "fire-fighting" mode.
If the U.S. Supreme Court
rules in favor of Wyeth, upholding the pre-emption rule, it takes away one of
the major legal remedies the average U.S. citizen has when events such as Diana
Levine's nightmare occurs.
And yes, politics, notably
the Bush administration, is solidly evident. The Bush Administration has moved
stealthily to prevent state common law claims.
In January 2006, the FDA
adopted new regulations, the ultimate purpose was to torpedo efforts to allow
personal injury claims to be heard by state court juries.
The FDA said "it is the
expert federal public agency charged by Congress with insuring that drugs are
safe and effective and that their labeling adequately informs users of the
risks and benefits of the product and is truthful and not misleading." Translation: "if we say it won't
kill you, it won't kill you."
And since when is the FDA in
the job of insuring anything?
These are the same folks who can even inspect imported food to make sure
it is safe.
Take all the extremely
technical legal argument out of this and there is still the factor of human
error, of an understaffed agency monitoring an exponentially growing number of
pharmaceutical products, and the potential for this agency to slam the door in
a citizen's face should a medical catastrophe occur.
In May, the Congressional Committee on Oversight and Government
Reform held hearings on the pre-emption issue. Chairman, Rep. Henry Waxman,
said in his statement, that if the pharmaceutical managers, the FDA and the
Bush Administration have their way in court, "...one of the most powerful
incentives for safety, the threat of liability, would vanish."
Whose
body is it anyway? Yours, or the
FDA's? Onward. Richard Alexander
This page is an archive of entries from June 2008 listed from newest to oldest.
May 2008 is the previous archive.
July 2008 is the next archive.
|  |